REMUS has successfully incorporated its new subsidiary, Espee Global Clinical Trial Services Private Limited.

Remus Pharmaceuticals LimitedREMUS · Filed with the exchange

This marks a significant business development, officially establishing the entity under the Companies Act.

This expansion builds on the previously announced approval, enhancing the company's operational capabilities and potential for future growth in clinical trial services.

Read the original filing(PDF)

No comments yet. Be the first.

More from Remus Pharmaceuticals Limited

All announcements

Others08-09-2026
Copy of Newspaper Publication
Dividend/Bonus07-09-2026
Record Date
Others07-09-2026
Shareholders meeting
Others06-09-2026
Copy of Newspaper Publication
Others05-09-2026
Shareholders meeting
Others03-09-2026
Copy of Newspaper Publication

Free

Track this company, and every filing it makes

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

Create a free account

No card needed. Takes about a minute.